Jennifer E. Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians should monitor children when considering adalimumab discontinuation.
Trisha Miglani, MD
Advertisement
Trisha Miglani, MD, is an ophthalmology resident with the Department of Ophthalmology at NYU Grossman School of Medicine in New York, New York.
Articles by Trisha Miglani, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
International meta-analysis highlights elevated ocular risk in Clade I Monkeypox
5